Edition:
United States

ARCA Biopharma Inc (ABIO.OQ)

ABIO.OQ on NASDAQ Stock Exchange Capital Market

1.65USD
20 Feb 2018
Change (% chg)

-- (--)
Prev Close
$1.65
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
30,055
52-wk High
$2.75
52-wk Low
$1.05

Chart for

About

ARCA biopharma, Inc. (ARCA) is a biopharmaceutical company. The Company is principally focused on developing genetically-targeted therapies for cardiovascular diseases. The Company's lead product candidate is Gencaro (bucindolol hydrochloride), a beta-blocker and mild vasodilator that the Company is evaluating in a clinical... (more)
No analyst recommendations are available for .

Overall

Beta: 0.95
Market Cap(Mil.): $19.39
Shares Outstanding(Mil.): 11.75
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.45 17.28
EPS (TTM): -- -- --
ROI: -- 14.04 35.61
ROE: -- 15.50 17.17

BRIEF-Arca Biopharma announces issuance of European patent on cardiovascular disease treatment methods

* Arca Biopharma announces issuance of European patent for treating cardiovascular diseases and conditions with a new chemical entity utilizing genetic targeting

Nov 16 2017

BRIEF-ARCA Biopharma announces third quarter financial results

* ARCA Biopharma announces third quarter 2017 financial results and provides business update

Nov 09 2017

Competitors

  Price Chg
Pfizer Inc. (PFE.N) $36.01 -0.25
Novartis AG (NOVN.S) CHF79.94 -0.52
Merck & Co., Inc. (MRK.N) $54.98 -1.31
Roche Holding Ltd. (ROG.S) CHF222.65 -1.25
Roche Holding Ltd. (RO.S) CHF226.00 -0.80
Abbott Laboratories (ABT.N) $59.12 -1.05
Bayer AG (BAYGn.DE) €98.54 -0.39
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €64.15 -0.40
Eli Lilly and Co (LLY.N) $77.55 -1.42

Earnings vs. Estimates